"Don't Be Frail to Optimize Heart Failure Therapies!"
- PMID: 35361447
- DOI: 10.1016/j.jchf.2022.01.006
"Don't Be Frail to Optimize Heart Failure Therapies!"
Keywords: frailty; guideline-directed medical therapy; heart failure with reduced ejection fraction.
Conflict of interest statement
Funding Support and Author Disclosures Drs Mewton and Sebbag have received honorary or consultant funds from Novartis, AstraZeneca, Boehringer Ingelheim, Amgen, Bayer, Vifor Pharma, Merck Sharp & Dohme, and Bristol Myers Squibb.
Comment on
-
Frailty, Guideline-Directed Medical Therapy, and Outcomes in HFrEF: From the GUIDE-IT Trial.JACC Heart Fail. 2022 Apr;10(4):266-275. doi: 10.1016/j.jchf.2021.12.004. Epub 2022 Mar 9. JACC Heart Fail. 2022. PMID: 35361446 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
